alopecia areata. other alopecia areata
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: age> 18 years old AA coverage <25% of scalp surface presence of 2-5 patches discontinue of intralesional triamcinolone treatment at least 2 weeks earlier stable disease without the appearance of a new patch or increase in the size of the patches for at least 15 days
Exclusion criteria
Exclusion criteria: allergy or hypersensitivity to any component of treatment products pregnancy or lactation any skin infection on treatment area severe medical illness simultaneous use of immunosuppressant or anticoagulant medication progressive disease posetive hair pull test
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Terminal hair growth change. Timepoint: The patients will be assessed in 2 every 2 weeks visits for procedures, and 3 months after the first visit. Method of measurement: ?Terminal hair growth change garde into following 6 grade:Grade 0:no change or further hair loss /Grade 1: regrowth of 1-24% terminal hair /Grade 2: regrowth of 25-49% terminal hair /Grade 3: regrowth of 50-74% terminal hair /Grade 4: regrowth of 75-99% terminal hair /Grade 5:regrowth of 100% terminal hair. | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of patch size change. Timepoint: ?The patients will be assessed in 2 every 2 weeks visits for procedures, and 3 months after the first visit. Method of measurement: Rate of size change (%)= Baseline size-Follow up size/Baseline size ×???.;Patient satisfaction. Timepoint: ?The patients will be assessed in 2 every 2 weeks visits for procedures, and 3 months after the first visit. Method of measurement: A 5-point scale. 4: Extremely satisfied, 3:Very satisfied, 2: satisfied, 1: Slightly satisfied, 0: Not satisfied. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz University of Medical Sciences